A Rapid, Cost-Effective Pre-Clinical Method to Screen for Pro- or Antiarrhythmic Effects of Substances in an Isolated Heart Preparation

Tekijä Borg, John Joseph
Julkaisussa Sci Pharm (2015)

Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJ

Tekijä Borg, John Joseph, Laslop, Andrea, Pani, Luca, Maciulaitis, Romaldas, Melchiorri, Daniela
Julkaisussa Sci Pharm (2014)

Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective

Tekijä Refalo, Nathaniel, Chetcuti, Daniel, Tanti, Amy, Serracino-Inglott, Anthony, Borg, John Joseph
Julkaisussa Saudi Pharm J (2017)

Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective

Tekijä Borg, John Joseph, Tomasi, Paolo, Pani, Luca, Aislaitner, George, Pirozynski, Michal, Leufkens, Hubert, Melchiorri, Daniela
Julkaisussa Sci Pharm (2014)

European Union pharmacovigilance capabilities: potential for the new legislation

Tekijä Borg, John Joseph, Tanti, Amy, Kouvelas, Dimitrios, Lungu, Calin, Pirozynski, Michal, Serracino-Inglott, Anthony, Aislaitner, George
Julkaisussa Ther Adv Drug Saf (2015)